Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the market size evolved in recent years?
In the last few years, the scleritis market has seen significant growth. The market, which is projected to be worth $3.60 billion in 2024, is expected to expand to $3.94 billion in 2025, marking a compound annual growth rate (CAGR) of 9.3%. The surge in the previous years can be credited to a rise in the instances of autoimmune disorders, increased understanding of eye health, a growing elderly population, better availability of eye care services, and a worldwide advancement in healthcare infrastructure.
What are the predictions for the market size in the coming years?
Projected robust growth can be foreseen in the scleritis market’s size in the coming few years. A compound annual growth rate (CAGR) of 8.9% indicates an estimated growth amounting to $5.54 billion by the year 2029. Driving factors for this growth during the projection period include the escalation of eye-related health issues, an increment in ocular health consciousness, increase in health care expenditure, extension in ophthalmology research, amplified requirement for individualized medicine, and an upsurge in treatment options. In the forecast period, the main trends are anticipated to comprise the evolution of targeted biological treatments, enhanced formulations of immunosuppressive drugs, breakthroughs in imaging technology, the adoption of minimally invasive tools for diagnosis, the inclusion of personalized medicine approaches, the progression in drug delivery systems, and solutions for diagnostic and treatment planning stimulated by AI.
Get your market report here!
https://www.thebusinessresearchcompany.com/report/scleritis-global-market-report
What are the leading drivers of growth in the market?
The escalating occurrence of autoimmune diseases is predicted to stimulate the expansion of the scleritis market in the future. These diseases are medically defined as conditions where the human body’s immune mechanism wrongfully targets its healthy cells and tissues, misinterpreting them as foreign threats. The increase in such diseases is tied to hereditary susceptibilities, environmental elements, modifications in lifestyle, and heightening consciousness which enhances the rates of diagnosis. Autoimmune diseases instigate scleritis by setting off an inflammatory immune reaction which mistakenly assaults the scleral tissue, thereby causing discomfort and redness. For example, as stated by Versorgungsatlas.de, a German-based firm, in November 2024, in 2022, from a total of 73,241,305 insured people, 6,304,340 were identified with at least one autoimmune disease, resulting in a crude prevalence percentage of 8.61%. As such, the escalating occurrence of autoimmune diseases is propelling the expansion of the scleritis market.
How is the global market divided into key segments?
The scleritis market covered in this report is segmented –
1) By Type: Anterior Scleritis, Posterior Scleritis, Other Types
2) By Treatment: Medication, Surgery, Other Treatment
3) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channel
4) By End-Users: Hospitals, Specialty Clinics, Home Healthcare, Other End-Users
Subsegments:
1) By Anterior Scleritis: Non-Necrotizing Anterior Scleritis, Necrotizing Anterior Scleritis
2) By Posterior Scleritis: Diffuse Posterior Scleritis, Nodular Posterior Scleritis, Scleritis With Choroidal Involvement
3) By Other Types: Chronic Scleritis, Recurrent Scleritis, Infectious Scleritis
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21283&type=smp
Who are the key firms paving the way for growth in the market?
Major companies operating in the scleritis market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceuticals USA Inc., Baxter International Inc., Boehringer Ingelheim, Regeneron Pharmaceuticals Inc., Fresenius Kabi USA LLC, Sun Pharmaceutical Industries Ltd., Perrigo Company, Horizon Therapeutics plc, Aurobindo Pharma Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals, Alvogen, Accord Healthcare, West-Ward Pharmaceuticals, Jubilant Cadista Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Zydus Pharmaceuticals Inc.
What emerging trends are influencing the growth of the market?
In an effort to provide improved, non-invasive treatment solutions for patients, leading companies in the scleritis market are concentrating their efforts on creating highly developed products like eye drops. These eye drops, which are liquid solutions engineered specifically to directly target eye conditions such as dryness, infections, irritation, and inflammation, serve as an important advancement in treatment options. Entod Pharmaceuticals, a pharmaceutical company based out of India, introduced CYCLOTEARS eye drops across India and worldwide in May 2023. Employing proprietary SEDDS technology, this groundbreaking treatment for inflammatory eye disease significantly enhances the drug’s delivery and effectiveness, offering an innovative way to combat inflammation in DED. It represents a notable progress in the treatment of eye inflammation, ocular myositis, and scleritis.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21283
What regions are contributing significantly to the growth of the market?
North America was the largest region in the scleritis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the scleritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Hepatitis B Virus (HBV) Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report
Rotavirus Prophylaxis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/rotavirus-prophylaxis-global-market-report
Herpes Simplex Virus Treatment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
